We have located links that may give you full text access.
Topical gene editing therapeutics using lipid nanoparticles: "gene creams" for genetic skin diseases?
British Journal of Dermatology 2023 December 28
Patients living with inherited skin diseases have benefitted from recent advances in DNA sequencing technologies that provide new or improved diagnostics. However, developing and delivering new treatments for the "genodermatoses" remains challenging. The goal of creating topical preparations that can recover the inherent gene pathology remains largely aspirational. However, recent progress in two fields, the chemistry of topical delivery formulations (lipid nanoparticles) and the molecular biology of gene repair (CRISPR-Cas9, base and prime editing), now presents new opportunities to address that unmet need. In this review, we discuss how lipid nanoparticle delivery vehicles could be used to deliver gene editing tools to formulate topical "gene creams" suitable for the treatment of genodermatoses. We summarise the historical landscape of topical therapeutics and advances in gene editing which may herald an era of new therapies for patients with inherited skin disorders.
Full text links
Related Resources
Trending Papers
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app